Speciality European Pharma (SEP) is a privately owned, specialist pharmaceutical company with a key focus on urology. SEP work throughout Europe and beyond to market and improve its products available to treat urological conditions.
SEP’s goal is to become Europe’s leading specialist urology focused pharmaceutical company through organic development of its existing product portfolio and through further acquisitions and licensing. SEP aims to be considered the partner of choice for companies seeking to register and market their urology products in Europe.
Caution: Aquamid(R) and Bulkamid(R) are investigational devices in the United States and limited by Federal (or United States) law to investigational use. They are not available for sale in the United States.
More information:
info@spepharma.com
Company Details
- Employees
- 13
- Founded
- -
- Address
- 14 Took's Court, London,ec4a 1lb,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- specialityeuropeanpharma.com
- Keywords
- Rome.
- HQ
- London
Speciality European Pharma Questions
Speciality European Pharma's website is specialityeuropeanpharma.com
Speciality European Pharma's LinkedIn profile is https://uk.linkedin.com/company/speciality-european-pharma
Speciality European Pharma has
13 employees.
View email and phone details for 13
employees at Speciality European Pharma.
Speciality European Pharma's industry is
Pharmaceutical Manufacturing
Speciality European Pharma's top competitors are
Spemital - S.p.a.,
Merck Serono S.p.a.,
Visufarma Uk,
3a Pharma,
Ipafarma,
B-Pharma Group,
Inca-Pharm S.r.l.,
Donawa Lifescience,
Fmc Lab,
Visufarma - The Eye Health Company.
Speciality European Pharma's categories are Pharmaceutical Manufacturing
Speciality European Pharma's founding year is 2006
